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ABSTRACT
BACKGROUND: The serious nature of potentially malignant oral lesions (PMOL) demands that the final
diagnosis be made on both clinical and histopathologic grounds. The aim of the present study was to
determine the correlation between clinical and histopathologic diagnoses of PMOL using a discrepancy
index (DI).
METHODS: Fifty-one patients with PMOL were examined clinically, and a biopsy was taken from each
one. The results of histopathologic diagnosis were compared with the clinical diagnosis. We established
that the histopathologic diagnosis was incompatible when the clinical diagnosis was not confirmed. On
the basis of the incompatible diagnosis, we calculated a discrepancy index between the clinical and
histopathologic diagnosis.
RESULTS: Clinically, the homogeneous leukoplakia was the most frequent lesion followed by erosive
lichen planus and reticular lichen planus. No cases of erythroplakia were observed. Lesions were most
frequently seen at the buccal mucosa, followed by the gingiva (alveolar mucosa) and tongue. The
histopathologic diagnosis showed that the majority of the lesions were benign keratoses followed by
lichen planus. Three cases of epithelial dysplasia were mild. The DI between clinical and histopatholog-
ic diagnosis was 17.6 %. The higher DI was found in erosive lichen planus.
CONCLUSION: The obtained findings show that in 90% of leukoplakias, clinical diagnosis was confirmed
by histopathologic examination. The discrepancy between clinical and histopathologic diagnoses in 17.6
% of cases suggests that all PMOLs should be submitted to histological analysis.
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INTRODUCTION 
A
potentially malignant oral lesion (PMOL) has been defined as a morphologically altered
tissue in which cancer is more likely to develop than in its apparently normal counter-
part. Leukoplakia is the most common potentially malignant lesion of the oral mucosa (1).
It has been suggested that widespread multiple leukoplakias may have a higher potential for
developing carcinoma regardless of the grade of epithelial dysplasia (2). Although some
previous studies have shown generally poor agreement among pathologists in the
histopathologic assessment of oral premalignant lesions (3,4), the taking of a biopsy in
leukoplakias should be the standard rule. The problem in such lesions is not so much the
histopathologic evaluation of the presence of epithelial dysplasia as it is the possible inva-
sive nature of the lesion (5).
Oral lichen planus (OLP) is one of the most prevalent oral mucosal lesions with an increased
potential for malignant development (6). Because of the variations in appearance, the diag-
nosis of OLP should not be assessed on the histopathologic picture alone, but should also
be based on distinct clinical criteria. Histopathologically, typical OLP in a substantial per-
centage does not correlate with a typical clinical appearance (7).
The management of PMOL is problematical and is largely dependent on the collection of
both clinical and histopathologic information.
The aim of the present study was to determine the correlation between clinical and
histopathologic diagnoses of PMOL using the discrepancy index.
PATIENTS AND METHODS
The study population comprised 51 patients (31 women and 20 men) aged from 42 to 76
years, who visited the Department of Oral Medicine and Periodontology of the Clinic of
Stomatology in Novi Sad, between January 2002 and December 2003. After the patients
had provided their consent form, all clinical examinations were performed by one of the
authors, with 20-year experience in the diagnostics of oral mucosal lesions. A history was
taken from each patient, and the exact location of all lesions were noted down in a case
report form, which contained a schematic presentation of the dorsal and ventral view of the
mouth, including lips, labial mucosa, gingiva, vestibule, buccal mucosa, floor of mouth,
hard palate, soft palate and tongue. The lesions presented clinically as: (i) homogeneous
leukoplakia; (ii) non-homogeneous leukoplakia; (iii) erythroplakia; (iv) lichen planus, and (v)
actinic cheilitis were determined to be potentially malignant lesions. The clinical diagnosis
was reached according to the criteria described in Table 1. 
Histopathologic examination of all lesions was performed. If the lesions were small, an exci-
sional biopsy was usually performed. For the large lesions, an incisional biopsy was per-
formed and multiple specimens from different areas were taken. The biopsy specimenswere fixed in 10% formalin, embedded in paraffin, cut, and stained with hematoxylin-eosin
by the standard laboratory procedure. The lesions were histopathologically diagnosed as:
benign keratosis, epithelial dysplasia, lichen planus, and actinic cheilitis (8). The
histopathologic diagnoses were made by an experienced pathologist using the criteria
described in Table 2.  In the case of multiple biopsies, the severest histopathologic diag-
nosis was considered as the final result.
The histopathologic diagnosis was compared with clinical diagnosis. The histopathologic
diagnosis was considered incompatible with the clinical diagnosis when the clinical diag-
nosis was not confirmed. We calculated a discrepancy index (DI): (the number of incom-
patible diagnosis/the number of total sample) x 100  (9).
RESULTS
Clinically, leukoplakia (homogeneous and nonhomogeneous) was the most   frequent
lesion followed by erosive and reticular lichen planus. The majority of the patients present-
ed multiple lesions in oral mucosa. Among 26 homogeneous leukoplakias, gingiva (n=15)
and buccal mucosa (n=10) were the major affected sites, whereas buccal mucosa (n=3),
gingiva (n=2), and palate (n=2) were predominantly affected with nonhomogeneous
leukoplakias (Table 3). No cases of erythroplakia were observed.
The histopathologic examination indicated that the majority of the lesions were benign ker-
atoses. Three cases of epithelial dysplasia were mild. In 5 cases of lichen planus, clinical
diagnosis was not confirmed by the histopathologic examination. In one case with clinical
characteristics of erosive lichen planus, the histopathologic diagnosis was cheilitis solaris
(Table 4). The DI between clinical and histopathologic diagnoses was 17.6%. The higher DI
was found in the group of lesions clinically defined as erosive lichen planus.
DISCUSSION
In the present study, the most common clinically found PMOL was leukoplakia, (58.9% of
the sample analyzed). This finding is in agreement with those from previous reports
(9,10,11). The most frequent location of leukoplakia was gingiva (alveolar mucosa), fol-
lowed by buccal mucosa and lip vermilion. The manifestations of OLP were by far the most
prevalent in buccal mucosa, followed by tongue and gingiva (alveolar mucosa). Our previ-
ous study showed the same frequencies of the affected locations among individuals with
oral lichen planus (12), which is in accord with other studies (13-16).
The histopathologic diagnosis showed that benign keratosis was the most frequent PMOL.
In 92.3% of leukoplakias, clinical diagnosis was confirmed by the histopathologic exami-
nation. The histopathologic analysis showed that three cases clinically diagnosed as leuko-
plakias were, in fact, OLP. In these cases, OLP appeared as a white plaque unilaterally
located, without a reticular pattern, and therefore diagnosed as leukoplakia. Although these
three cases contributed to the increase in the DI, no histologic examination might lead to
misdiagnosis and therapeutic errors. This finding leads to a conclusion that a biopsy should
always be taken from a plaque lesion. In addition, the differential diagnosis between plaque-
like OLP and leukoplakia can be obtained by histopathologic analysis since these two con-
ditions are clinically similar (7). In five cases with a clinical diagnosis of erosive lichen
planus, the histopathologic diagnosis revealed non-specific chronic inflammatory process.
In all these cases, the surface erosion existed, with the destruction of the epithelium, leav-
ing only the fibrin-covered granulation tissue at the floor of the lesion. In the present study,
the correlation between the clinical and histological diagnoses of OLP was missing in 5
cases, which contributed to the higher DI. This finding suggests that in the diagnosing of
OLP we cannot rely on a clinical or histological diagnosis alone. Also, we think that the clin-
ical diagnosis was not confirmed in these cases because the biopsy specimens were inad-
equate, exhibiting only an ulcerated surface. The biopsy of lesioned tissue, particularly if
OLP is of an erosive form, can be challenging. A biopsy specimen of predominantly ery-
thematous and ulcerated mucosal lesions should be taken few millimeters away from an
ulcer so that the specimen’s epithelium and connective tissue remains intact (17). It has
been suggested that punch biopsies provide greater interobserver reliability than wedge
biopsies in the histopathologic diagnostics of PMOL (18).
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Table 1. The criteria for clinical diagnosis of potentially malignant oral lesions
Table 2. The criteria for histopathologic diagnosis of potentially malignant oral lesions
Table 3. Distribution of patients with PMOLs by clinical diagnosis, sex and anatomical location
Table 4. Distribution of  PMOLs according to histopathologic and clinical diagnosesIn one case with a clinical diagnosis of erosive lichen planus, the histopathologic diagnosis
was cheilitis solaris. In this case, clinically considered, the lesion presented an erythema-
tous surface with an eroded vermilion, from which part of the biopsy was taken, and also a
bilateral reticular pattern on buccal mucosa. The difference in the clinical and histopatho-
logic diagnoses might be partly caused by the fact that the clinical information did not
accompany the biopsy specimen and the pathologist was not aware of the clinical presen-
tation and exact location of the lesion. In a somewhat similar study regarding the presence
and degree of epithelial dysplasia, the inclusion of clinical information did not improve the
interobserver agreement rate in the diagnosis of oral epithelial dysplasia (19). In addition,
Fischer and coworkers (18) reported the least agreement on histopathologic diagnosis for
lip and labial mucosa lesions compared with other mucosa sites. Moreover, van der Meij
and co-workers (20,21) reported that interobserver agreement in the clinical and the histo-
logical assessments of OLP, defined by kappa, varied from poor to moderate and from
moderate to substantial, respectively. The intraobserver agreement appeared to be signifi-
cantly higher in both studies. 
In our study the DI was 17.6%. The discrepancy between the clinical and the histopatho-
logic diagnoses of erosive OLP significantly contributed to the increase in the DI. However,
Onofre and coworkers (9) found a DI of 24.4%, and the higher DI was detected among the
homogeneous and non-homogeneous leukoplakias although they investigated a smaller
number of cases with leukoplakia than the present study. Recently, the lack of the clinico-
histopathologic correlation in the diagnosing of OLP was found and therefore a set of
revised diagnostic criteria for oral OLP was proposed, based on the WHO definition of OLP,
including clinical as well as histopathologic aspects (7). Several studies have used biolog-
ic markers to identify the molecular genetic differences among PMOLs  (22-24). Thus, the
use of the molecular markers may lead to a more accurate histopathologic diagnosis of
PMOL and may, in the future, become the indicators of an adequate treatment.
In conclusion, the obtained results show that in 90% of leukoplakias, the clinical diagnosis
was confirmed by the histopathologic examination. The discrepancy between the clinical
and histopathologic diagnoses in 17.6% of cases suggests that all PMOLs should be sub-
mitted to a histopathologic analysis. 
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Correlation between prostate-specific antigen and histopatho-
logical difference of prostate carcinoma
Sla￿ana ﬁivkovi￿
ABSTRACT
BACKGROUND:Adenocarcinoma of prostate (ACP) is one of the most frequent tumors in men older than
50. Prostate specific antigen (PSA) is the most reliable serum marker in the diagnostics and following
of prostate carcinoma, and Gleason’s system of estimation of tumor differentiation, as well as classical
estimation of tumor differentiation from 1 to 3, are generally accepted systems of prostate carcinoma
evaluation.
METHODS: Forty examined individuals with verified ACP and compared values of PSA and
tumor differentiation as well as estimated comparability of these two systems are reported.
RESULTS: Highly positive correlation between the values of PSA in serum and the degree of tumor dif-
ferentiation determined by Gleason’s system, as well as the low correlation between PSA and histologi-
cal differentiation estimated using classical system from 1 to 3 were found.
CONCLUSION: It could be concluded that Gleason’s system for tumor differentiation determination is
more superior system of histological grade determination than the other systems.
KEY WORDS: Prostatic Neoplasms; Adenocarcinoma; Prostate-Specific Antigen; Neoplasm Staging;
Cytodiagnosis; Sensistivity and Specificity
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INTRODUCTION 
P
rostate-specific antigen (PSA) is the most useful tumor marker in the diagnostics of
prostate carcinoma (1). PSA is serin protease produced by ductal and acinal epithelial
cells of normal, hyperplastic, and malignant tissue of the prostate. By the influence of
pathological processes the cell integrity is destroyed leading to release of PSA into circula-
tion, i.e. the processes inside prostate, such as hyperplasia, inflammation, tumors, lead to
the increase of serum PSA value the most frequently (2-4). The investigations have revealed
that every gram of cancer prostate tissue increases the value of serum PSA for 2.3 ng/ml
in average, while every gram of hyperplastic tissue increases the same parameter 10 times
less compared to cancer tissue (5,6). The PSA value increase is determined by histologi-
cal characteristics of epithelial cells. In neoplastic processes the increase of serum PSA
depends on differentiation of tumor cells. The less differentiated prostate tumors can cause
lower PSA concentrations in comparison to those well differentiated (7). In prostate carci-
noma (PC) evaluation there are few systems used for estimation of tumor cells differentia-
tion i.e. histological grade of tumor. In literature the grade systems suggested by Mostofi,
Broders, and Gleason are the most cited. Classical determination of histological grade
according to Mostofi is based on criteria of nuclear anaplasia and formation of gland struc-
tures. According to this system prostate carcinoma could exert three histological grades:
grade 1 (well differentiated), grade 2 (moderately differentiated), and grade 3 (poorly differ-
entiated) (8).
Meanwhile, Gleason’s system (GGS) is nowadays one of the most used grade systems in
PC (9). The base of GGS is represented by five histological figures, which, using small
microscopic magnification, encompass analysis of gland architectonics, the degree of glan-
dular differentiation as well as stromal invasion, but not the degree of nuclear anaplasia
(10,11). The aim of the work is to determine the relation between serum PSA and differen-
tiation of prostate carcinoma using Gleason’s system and classical determination of histo-
logical grade from 1 to 3, as well as to estimate comparability of these two systems.
MATERIALS AND METHODS
The investigation included 40 individuals in age from 60 to 79 years (average age, 69.9
years), who had the clinical symptoms of prostatism at digitorectal examination (DRE),
established enlargement of prostate suspected to malignant process or benign prostate
enlargement accompanied with PSA values above 4ng/ml. The investigation was carried out
at Urology Section and Section for Pathology at the Military Hospital in Ni„, at the Clinic for
Urology and Institute for Pathology of Clinical Center Ni„, and in the radioisotopic laborato-
ry "Pharmacia Diagnostica" in Ni￿ in the period from January 2002 to January 2003. Beside
the basic disease the examined individuals didn’t have any other health disorder which could
significantly influence the function of urinary tract. All patients have been taken a standard
urological examination according to modified protocol in keeping with diagnostic protocol
for prostate carcinoma (12) (Table 1).
Using this protocol the standard diagnostic methods have been applied: DRE, transabdom-
inal ultrasonography of prostate, determination of serum PSA, biopsy of prostate.
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Table 1. Modified diagnostic protocol for prostate carcinoma